SynCell has been selected as finalist in the first round of the Medical Innovation Challenge at the TechConnect World Conference

 

SynCell News • May 28, 2022

From hundreds of applications spanning cutting edge medical innovation from devices and sensors to therapeutic innovations and advanced material platforms, our company has made it to the first round of 2022 Medical Innovation Challenge finalists and have earned a spot to pitch at TechConnect World this June.

For over 20 years the TechConnect World Innovation Conference and Expo has connected top applied research and early-stage innovations from universities, labs, and startups with industry end-users and prospectors. The 2022 TechConnect World Innovation event includes the annual SBIR/STTR Innovation Conference, AI TechConnect, and the TechConnect Technical Program – more than 35 world-class technical symposium, and the Nanotech Conference Series – the world’s largest and longest running nanotechnology event.

Through these joint programs, TechConnect has published over 10,000 technical papers, connected over 20,000 innovations with industry partners, provided prospecting to most all Fortune 500 technology companies, and supported most every U.S. Science and Technology agency including the National Nanotechnology Initiative since its inception.